Making Pharmaceuticals Round Table “European pharmaceutical strategy: strengths and weaknesses”

20

The pandemic emergency and the current growing political uncertainty have impacted the global pharma supply chain, highlighting strengths and also weaknesses, revealing how manufacturers of active ingredients are in a key position to ensure the availability of medicines and counteract the phenomenon of supply shortages. However, competition from Asian and Indian countries has led to a slowdown in the production of active ingredients in Europe in recent years and to an increasing dependence in obtaining finished drugs.